Drug Shortage Report for METHOTREXATE INJECTION BP

Last updated on 2017-04-08 History
Report ID 3262
Drug Identification Number 02327236
Brand name METHOTREXATE INJECTION, BP
Common or Proper name METHOTREXATE
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS
Packaging size 20 ML VIAL OF 500 MG | FLACON DE 20 ML DE 500 MG
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2016-12-13
Actual start date 2016-12-13
Estimated end date 2017-04-19
Actual end date 2017-04-07
Shortage status Resolved
Updated date 2017-04-08
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-17 English Compare
v2 2017-03-17 English Compare
v3 2017-03-17 French Compare
v4 2017-04-07 English Compare
v5 2017-04-08 English Compare

Showing 1 to 5 of 5